Thyrocare diagnoses plans for $100m IPO

India’s Thyrocare Technologies is planning a domestic IPO worth $80m-$100m this year and has picked three banks to lead its listing. The diagnostics provider is set to provide investors with a chance to buy into a one-of-a-kind story, with bankers reckoning that the company’s unique business model will be a big hit.